MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 142M shares, a 7.3% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 132M shares, a 48.3% decline from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 255M shares, a 0.96% decline from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 258M shares, a 792% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 142M +9.63M +7.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 136M +3.98M +3.02% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 132M +594K +0.45% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 132M -123M -48.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 132M +279K +0.21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 132M -123M -48.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 132M -124M -48.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 255M -2.48M -0.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 132M -126M -49% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 255M +143M +127% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 255M +159M +164% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 258M +229M +792% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 258M +4.11M +1.62% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 112M -142M -55.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 96.7M -157M -61.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 28.9M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 254M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 254M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 254M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.